arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ALX ONCOLOGY HOLDINGS INC

ALXO

$2.09 ▼ -0.04 (-1.88%) at close

9 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

ALX ONCOLOGY HOLDINGS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $112.1M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -287.8% ↘

FCF / Share $-1.57 ↗

Trailing P/E —

Price / Book 4.4x

FCF Yield —

Debt / Equity 0.39

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-101.69M

↑ +24.6% —

FCF / Share Free cash flow per share

$-1.57

↑ +33.0% —

Long-Term Debt Long-term obligations

$10.16M

↑ +7.4% —

Health Breakdown

Financial Health ↑

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	N/M	-75.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1042%)	132.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1550%)	—	—
EPS Growth YoY (%)	26.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	31.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-23.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-46.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	24.6% Good ↑ Good Improving Year-over-year change in net income	16.1% Good ↑ Good Improving Year-over-year change in net income	-30.2% Weak ↑ Weak Improving Year-over-year change in net income	-47.9% Weak ↑ Weak Improving Year-over-year change in net income	-82.5% Weak ↑ Weak Improving Year-over-year change in net income	-137.7% Weak Weak Year-over-year change in net income	-40.1% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	33.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	23.4% Good ↑ Good Improving Year-over-year change in free cash flow	-37.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	-30.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	17.7% Good ↓ Good Declining Year-over-year change in free cash flow	56.3% Excellent Excellent Year-over-year change in free cash flow	5.7% Fair Fair Year-over-year change in free cash flow	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	-400.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2767%)	—	—
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	—	—	—	-401.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3444%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	-304.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-287.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-115.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-67.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	29.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	26.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-176.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-96.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-70.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-179.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	-118.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-891%)	-84.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-665%)	-46.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-23.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	27.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+82%)	26.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+77%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	0.39x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.08x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	—	—	-0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-113%)	—	—
Interest Coverage (x)	-64.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-82.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-108.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1237.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7595.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	-102.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-6.21M	$-8.10M	$-11.81M	$-38.22M	$-363.67M	$-434.22M	$-3.60M	—	—
Debt / EBITDA (x)	-0.10x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	—	—	—	$0.00	$0.00	$0.06	$1.56	$0.75	—
Basic EPS, GAAP (USD)	$-1.90	$-2.58	$-3.74	$-3.03	$-2.07	—	—	—	—
Free Cash Flow per Share (USD)	$-1.57	$-2.35	$-3.06	$-2.23	$-1.71	$-2.07	$-4.75	$-5.03	—
Book Value per Share (USD)	$0.48	$2.14	$3.80	$6.45	$8.94	$10.79	$-22.31	$-18.82	—
Tangible Book Value per Share (USD)	$0.48	$2.14	$3.80	$6.45	$8.94	$10.79	$-22.31	$-18.82	—
Basic Weighted Avg Shares (shares)	53.66M	52.17M	42.99M	40.70M	40.31M	18.49M	3.08M	2.75M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$26.17M	$115.85M	$152.66M	$242.64M	$351.72M	$429.79M	$4.83M	—	—
LT Debt (USD)	$10.16M	$9.47M	$10.60M	$10.60M	—	—	$5.42M	—	—
Total Equity (USD)	$25.98M	$113.62M	$189.71M	$263.46M	$363.05M	$429.85M	$-70.64M	$-51.78M	$-38.41M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$0.00	$0.00	$1.18M	$4.80M	$2.07M	—
Depreciation Expense (USD)	$706.00K	$872.00K	$836.00K	$342.00K	$51.00K	$202.00K	$429.00K	$431.00K	—
Net Income, GAAP (USD)	$-101.69M	$-134.85M	$-160.81M	$-123.48M	$-83.46M	$-45.74M	$-19.24M	$-13.73M	—
Operating Cash Flow (USD)	$-84.14M	$-121.91M	$-130.36M	$-89.22M	$-68.10M	$-38.29M	$-14.25M	$-13.19M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 31 quarters

ALX ONCOLOGY HOLDINGS INC

Analytical Summary

9-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ALXO with peers